Your session is about to expire
← Back to Search
Pembrolizumab for Solid Tumors
Study Summary
This trial will test to see if the experimental drug combination can help improve the survival rate for people with Leptomeningeal Metastases.
- Solid Tumors
- Leptomeningeal Metastasis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 57 Patients • NCT03004183Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What are the most common reasons that doctors prescribe Pembrolizumab?
"Pembrolizumab is most commonly used to fight cancer, but it can be employed in the treatment of other conditions such as microsatellite instability high and disease progression after chemotherapy."
Are there long-term negative effects to Pembrolizumab treatment?
"While there is some evidence that Pembrolizumab is safe for human consumption, it only received a score of 2 because this is still a Phase 2 trial and there is no data supporting efficacy."
Are there any slots available for new patients in this trial?
"The most recent information from clinicaltrials.gov suggests that this trial is still actively recruiting patients. The listing for the trial was first posted on March 8th, 2021 and updated September 22nd, 2021."
How many people can join this particular clinical trial?
"The most recent information on clinicaltrials.gov suggests that this trial is still looking for subjects. The study was originally posted on March 8th, 2021 and has been edited as recently as September 22nd, 2021. They need 19 patients from 2 different locations."
What is the research history of Pembrolizumab?
"Pembrolizumab is being trialed in 1076 active studies, 134 of which are in Phase 3. While some trials for Pembrolizumab are taking place in Sacramento, California, this medication is being tested in 37366 different locations globally."
Share this study with friends
Copy Link
Messenger